Homeopathy for attention deficit/hyperactivity disorder or hyperkinetic disorder

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2007, Pages

  Coulter, Morag K ^a   Dean, M E ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b NONE

Author keywords

Attention deficit disorder with hyperactivity *drug therapy ; Child; Homeopathy *methods ; Humans; Hyperkinesis *drug therapy ; Randomized controlled trials as topic

Indexed keywords

PLACEBO; POTASSIUM DIHYDROGEN PHOSPHATE; SELENIUM;

ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; FOLLOW UP; HOMEOPATHY; HUMAN; HYPERACTIVITY; HYPERKINESIA; IMPULSIVENESS; MENTAL INSTABILITY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 44949199279     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005648.pub2     Document Type: Review

References (70)

1. Frei 2005 {published and unpublished data} *Frei H, Everts R, von Ammon K, Kaufmann F, Walther D, Hsu-Schmitz S, Collenberg M, Fuhrer K, Hassink R, Steinlin M, Thurneysen A. Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised double-blind, placebo-controlled crossover trial. European Journal of Pediatrics 2005;164(12):758-767.
2. Jacobs 2005 {published and unpublished data} *Jacobs J, Williams A, Girard C, Njike VY, Katz D. Homeopathy for attention-deficit/ hyperactivity disorder: a pilot randomized controlled trial. Journal of Alternative and Complementary Medicine 2005;11(5):799-806.
3. Lamont 1997 {published data only} Lamont J. Homeopathic treatment of attention deficit hyperactivity disorder: a controlled trial. British Homeopathic Journal 1997;86:196-200.
4. Strauss 2000 {published and unpublished data} *Strauss LC. The efficacy of a homeopathic preparation in the management of attention deficit hyperactivity disorder. Biomedical Therapy 2000;18(2):197-201.
5. Frei 2001 Frei H, Thurneysen A. Treatment for hyperactive children: homeopathy and methylphenidate compared in a family setting. British Homeopathic Journal 2001;90:183-188.
6. Lamont 1998 Lamont J. Homeopathic treatment of attention deficit hyperactivity disorder: a controlled study. Biomedical Therapy 1998;16(3):219-222.
7. ADDISS 2003 ADDISS (The National Attention Deficit Disorder Information and Support Service). Parents, provision and policy: a consultation with parents. Southport: The National Attention Deficit Disorder Information & Support Service, 2003 (September).
8. APA 2000 American Psychiatric Association. Diagnostic and statistical manual for mental disorders. Fourth edition, Text revision (DSM-IV-TR). Washington DC: American Psychiatric Publishing Inc, 2000.
9. Barbaresi 2004 Barbaresi W, Katusic S, Colligan R, Weaver A, Pankratz V, Mrazek D, Jacobsen S. How common is attention-deficit/hyperactivity disorder? Towards resolution of the controversy: results from a population-based study. Acta Paediatrica 2004;93(Supplement 445):55-59.
10. Barkley 1990 Barkley RA. Attention-deficit hyperactivity disorder: a handbook for treatment and diagnosis. New York & London: Guilford Press, 1990.
11. Bland 1994 Bland MJ, Altman DG. Statistics Notes: regression to the mean. British Medical Journal 1994;308:1499.
12. Bradley 1937 Bradley C. The behavior of children receiving benzedrine. American Journal of Psychiatry 1937;94:577-85.
13. Brady 2004 Brady G. Children and ADHD: a sociological exploration. PhD Thesis 2004; Vol. University of Warwick.
14. Brue 2002 Brue AW, Oakland TD. Alternative treatments for attention-deficit/hyperactivity disorder: does evidence support their use?. Alternative Therapies in Health and Medicine 2002;8(1):68-70, 72-74.
15. Bussing 2002 Bussing, R, Zima, B T, et al. Use of complementary and alternative medicine for symptoms of attention-deficit hyperactivity disorder. Psychiatric Services 2002;53(9):1096-102.
16. CCT 1983 Lezak MD. Neuropsychological Assessment. New York: Oxford University Press, 1983:34-37, 547-551.
17. Chapman 1999 Chapman EH, Weintraub RJ, Milburn MA, Pirozzi TO, Woo E. Homeopathic treatment of mild traumatic brain injury: A randomized, double-blind, placebo-controlled clinical trial. Journal of Head Trauma Rehabilitation 1999;14(6):521-542.
18. Clark 2000 Clark J, Percivall A. A preliminary investigation into the effectiveness of the homoeopathic remedy, Ruta graveolens, in the treatment of pain in plantar fasciitis. British Journal of Podiatry 2000;3(3):8185.
19. Coghill 2004 Coghill D. Use of stimulants for attention deficit hyperactivity disorder. BMJ 2004;329(7471):907-908.
20. Collett 2003 Collett BR, Ohan JL, Myers KM. Ten-year review of rating scales. V: scales assessing attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry 2003;42(9):1015-37.
21. Conners 1973 Conners CK. Rating scales for use in drug studies with children. Psychopharmacology Bulletin 1973;special issue:24-28.
22. Conners 1995 Conners KC. Conners' Continuous Performance Test (CPT). Toronto: Multihealth Systems, 1995.
23. Conners 2001 Conners CK. Conners Rating Scales - Revised: Technical Manual. North Tonawanda, NY: Multi-Health Systems, Inc, 2001.
24. Cooper 1999 Cooper P, Bilton K. ADHD: Research, practice and opinion. London: Whurr Publishers, 1999.
25. Cucherat 2000 Cucherat M, Haugh MC, Gooch M, Boissel JP. Evidence of clinical efficacy of homeopathy: A meta-analysis of clinical trials. HMRAG: Homeopathic Medicines Research Advisory Group. European Journal of Clinical Pharmacology 2000;56(1):27-33.
26. Dantas 2000 Dantas F, Rampes H. Do homeopathic medicines provoke adverse effects? A systematic review. British Homeopathic Journal 2000;89 (Supplement 1):S35-38.
27. Dean 2004 Dean ME. The trials of homeopathy: origins, structure and development. Essen: Karl und Veronica Carstens-Stiftung, 2004.
28. Dean 2006 Dean ME, Coulter MK, Fisher P, Jobst K, Walach H. Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT. Forschende Komplementärmedizin/Research in Complementary Medicine 2006;13(6):368-71.
29. Egger 1997 Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997;315(7109):629-634.
30. Eiser 2001 Eiser C, Morse R. The measurement of quality of life in children: past and future perspectives. Journal of Developmental & Behavioral Pediatrics 2001;22(4):248-56.
31. Elbourne 2002 Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: Methodological issues. International Journal of Epidemiology 2002;31:140-149.
32. Frei 2006 Frei H, von Ammon K, Thurneysen A. Treatment of hyperactive children: increased efficiency through modifications of homeopathic diagnostic procedure. Homeopathy 2006;95:163-170.
33. Frei 2006a Frei H. Personal communication confirming data was not skewed (email to MKC) 31.08.2006.
34. Frei 2006b Frei H. Personal communication about recording information on side effects (email to MKC) 01.09.2006.
35. Frei 2006c Frei H. Personal communication about screening phase and treating physician (email to MKC) 23.10.2006.
36. Hahnemann 1913 Hahnemann S. Organon of the Rational Healing Art (Organon der rationellen Heilkunde). London: JM Dent, Everyman's Library, 1913 (Translation from 1810 German original to English by CM Wheeler).
37. Higgins 2002 Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Statistics in Medicine 2002;21(11):1539-1558.
38. Homeopathy 2006 Homeopathy. Volume 95 (1) 2006:1-64.
39. Hsu Schmitz 2006 Hsu Schmitz S-F. Personal communication providing mean and SD for main outcome variable (email to MKC) 22.10.2006.
40. Jacobs 2006 Jacobs J. Personal communication clarifiying details of the study medication (email response to MKC) 01.11.2006.
41. Johnston 2005 Johnston, C. Seipp, C, et al.Treatment choices and experiences in attention deficit and hyperactivity disorder: Relations to parents' beliefs and attributions. Child: Care, Health & Development 2005;31(6):669-677.
42. Kessler 2005 Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, Howes MJ, Jin R, Secnik K, Spencer T, Ustun TB, Walters EE. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychological Medicine 2005;35(2):245-256.
43. King 2006 King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R. A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Health Technology Assessment 2006; Vol. 10, issue 23.
44. Kleijnen 1991 Kleijnen J, Knipschild P, ter Riet G. Trials of homeopathy. BMJ 1991;302(6782):960.
45. Kunz 1998 Kunz R, Oxman AD. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. British Medical Journal 1998;317:1185-1190.
46. Laufer 1957 Laufer MW, Denhoff E, Solomons G. Hyperkinetic impulse disorder in children's behavior problems. Psychosomatic Medicine 1957;19:38-49.
47. Linde 1997 Linde K, Clausius N, Ramirez G, Melchart D, Eitel F, Hedges LV, Jonas WB. Are the effects of homoeopathy all placebo effects? A metaanalysis of randomized, placebo controlled trials. Lancet 1997;350:834-843.
48. Lord 2000 Lord J, Paisley S. The clinical effectiveness and cost-effectiveness of methylphenidate for hyperactivity in childhood. Version 2. London: NICE (National Institute for Clinical Excellence), 2000 (August).
49. Marshall 2000 Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M. Unpublished rating scales: A major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry 2000;176:249-252.
50. McCarney 2004 McCarney RW, Linde K, Lasserson TJ. Homeopathy for chronic asthma. Cochrane Database of Systematic Reviews 2004, Issue 1.Art. No.: CD000353. DOI:10.1002/14651858.CD000353.pub2.
51. MTA 1999 The MTA Cooperative group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD. Archives of General Psychiatry 1999;56(12):1073-1086.
52. NIMH 1985 National Institute of Mental Health (NIMH). CGI (Clinical Global Impression) Scale. Psychopharmacology Bulletin 1985;21:839-844.
53. Oxman 1992 Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Annals of Internal Medicine 1992;116(1):78-84.
54. Rebok 2001 Rebok G, Riley A, et al.Elementary school-aged chilren's reports of their health: A cognitive interviewing study. Quality of Life Research 2001;10(1):59-70.
55. RevMan 2003 The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) Version 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
56. Shang 2005 Shang A, Huwiler-Muntener K, Nartey L, Juni P, Dorig S, Sterne JA, Pewsner D, Egger M. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 2005;366(9487):726-732.
57. Simpson 2001 Simpson N, Roman K. Complementary medicine use in children: extent and reasons. A population-based study. British Journal of General Practice 2001;541(472):914-916.
58. Sinha 2005 Sinha, D, Efron D. Complementary and alternative medicine use in children with attention deficit hyperactivity disorder. Journal of Paediatrics & Child Health 2005;41(1-2):23-6.
59. Strauss 2006a Strauss L. Personal communication providing additional data (email to MKC) 27.10.2006.
60. Strauss 2006b Strauss L. Personal communication clarifying scoring method for PSQ (email to MKC) 25.11.2006.
61. Strauss 2007 Strauss L. Personal communication detailing randomisation procedures, diagnostic criteria and participant numbers (email to MKC) 06.02.2007.
62. TAP 1992 Zimmerman P, Fimm B. Testbatterie zur Aufmerksamkeitsprufung TAP Handbuch. Freiburg: Psychologische Testsysteme PsyTest, 1992.
63. Taylor 2000 Taylor MA, Reilly D, Llewellyn-Jones RH, McSharry C, Aitchison TC. Randomised controlled trial of homoeopathy versus placebo in perennial allergic rhinitis with overviewof four trial series. BMJ 2000;321(7259):471-476.
64. Thomas 2004 Thomas KJ, Coleman P. Use of complementary or alternative medicine in a general population in Great Britain. Results from the National Omnibus Survey. Journal of Public Health 2004;26(2):152- 157.
65. Thompson 2006 Thompson TDB, Weiss M. Homeopathy - what are the active ingredients? An exploratory study using the UK Medical Research Council's framework for the evaluation of complex interventions. BMC Complementary and Alternative Medicine 2006;6:37.
66. Timini 2003 Timimi S. Inappropriate use of psychostimulants. British Journal of Psychiatry 2003;183:173.
67. Wallander 2001 Wallander J L. Theoretical and developmental issues in quality of life for children and adolescents. Quality of Life in child and adolescent illness: concepts, methods and findings. Brunner-Routledge, 2001:23-47.
68. Weiser 1998 Weiser M, Strosser W, Klein P. Homeopathic vs conventional treatment of vertigo: a randomized double-blind controlled clinical study. Archives of Otolaryngology - Head & Neck Surgery 1998;124(8):879-885.
69. WHO 1992 World Health Organization (WHO). International Statistical Classification of Diseases and Related Health Problems (ICD-10). Geneva: World Health Organization, 1992.
70. Yusuf 1991 Yusuf S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 1991;266(1):93-98.